Chemistry researchers at Case Western Reserve University have identified specific markers that could pave the way for new ...

Evolucumab (Repatha) and alirocumab (Praluent) are injectable monoclonal antibodies. They have been joined by inclisiran ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...

Jax Bari, an 11-year-old from Philadelphia, shows me a photo of himself. It's hard to look at; in it, he's sprawled out on ...

The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

In the rapidly advancing field of molecular biology, techniques for studying protein interactions are constantly evolving. Among these, Surface Plasmon Resonance (SPR) stands out as a powerful ...

Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...

Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting ...

OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has entered into agreements for the ...